Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neuronetics Inc (STIM)
NASDAQ:STIM
Holding STIM?
Track your performance easily
STIM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.66 - $5.07
Previous Close$1.1
Volume7.77M
Average Volume (3M)329.71K
Market Cap
$33.34M
Enterprise Value$53.36M
Total Cash (Recent Filing)$42.60M
Total Debt (Recent Filing)$62.62M
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Mar 11, 2025EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding30,295,465
10 Day Avg. Volume1,046,779
30 Day Avg. Volume329,710
Standard Deviation0.35
R-Squared0.11
Alpha-0.00904
Financial Highlights & Ratios
Price to Book (P/B)1.08
Price to Sales (P/S)0.46
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit1.03
Enterprise Value/Ebitda-2.26
Forecast
1Y Price Target
$3.00Price Target Upside334.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Neuronetics News
PremiumCompany Announcements
Neuronetics Regains Nasdaq Compliance with Bid Price
PremiumCompany Announcements
Neuronetics Reports Growth and Strategic Acquisition
PremiumCompany Announcements
Neuronetics Sees Q3 Revenue Rise Amid Strategic AcquisitionBulls Say, Bears Say
Bulls Say
Financial PerformanceThe merger is expected to bring an accelerated pathway to profitability with expectations for positive adjusted EBITDA and cash flow in FY25.
Merger And SynergiesThe proposed merger combines the two entities to form a leading TMS therapy and service provider to patients and comes with both expected revenue and cost synergies.
Regulatory ApprovalThe company secured an FDA clearance for adjunct treatment for adolescent patients, which expands its TAM by ~35% and should contribute materially in 2025.
Bears Say
Cybersecurity BreachSTIM's second quarter reflected a top-line miss, as disruption from the Change Healthcare cybersecurity breach continued to impact the company's capital and treatment session sales.
Earnings GuidanceThe stock traded off notably following the company's first-quarter earnings release, likely due to macro headwinds discussed on the call as well as soft 2Q24 revenue guidance that was fairly below Street expectations.
Revenue ImpactSTIM’s Q2/24 missed estimates with $16.5M of revenue, driven by low treatment session revenue as customers delayed refilling inventory.
---
Ownership Overview
10.62% Insiders
9.83% Mutual Funds
1.31% Other Institutional Investors
73.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STIM FAQ
What was Neuronetics Inc’s price range in the past 12 months?
Neuronetics Inc lowest stock price was $0.66 and its highest was $5.07 in the past 12 months.
What is Neuronetics Inc’s market cap?
Currently, no data Available
When is Neuronetics Inc’s upcoming earnings report date?
Neuronetics Inc’s upcoming earnings report date is Mar 11, 2025 which is in 111 days.
How were Neuronetics Inc’s earnings last quarter?
Neuronetics Inc released its earnings results on Nov 12, 2024. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.229 by -$0.211.
Is Neuronetics Inc overvalued?
According to Wall Street analysts Neuronetics Inc’s price is currently Undervalued.
Does Neuronetics Inc pay dividends?
Neuronetics Inc does not currently pay dividends.
What is Neuronetics Inc’s EPS estimate?
Neuronetics Inc’s EPS estimate is -$0.21.
How many shares outstanding does Neuronetics Inc have?
Neuronetics Inc has 30,307,380 shares outstanding.
What happened to Neuronetics Inc’s price movement after its last earnings report?
Neuronetics Inc reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.229. Following the earnings report the stock price went down -37.273%.
Which hedge fund is a major shareholder of Neuronetics Inc?
Among the largest hedge funds holding Neuronetics Inc’s share is First Eagle Investment Management LLC. It holds Neuronetics Inc’s shares valued at 2M.
---
Neuronetics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (334.78% Upside)
$3.00 (334.78% Upside)
Hedge Fund Trend
Increased
By 301.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $257.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 4.1%
Last 30 Days ▲ 4.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.38%
12-Months-Change
Fundamentals
Return on Equity
-100.13%
Trailing 12-Months
Asset Growth
-3.56%
Trailing 12-Months
Company Description
Neuronetics Inc
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
---
STIM Earnings Call
Q3 2024
0:00 / 0:00
---
STIM Stock 12 Month Forecast
Average Price Target
$3.00
▲(334.78% Upside)
Technical Analysis
Best Analysts Covering STIM
1 Year
1 Year Success Rate
4/17 ratings generated profit
1 Year Average Return
-32.18%
reiterated a buy rating 3 months ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 23.53% of your transactions generating a profit, with an average return of -32.18% per trade.
---